PDE2A Produkte
(phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
Kategorien
activation induces decreased cAMP accumulation\; involved in nitric oxide mediated signaling in cardiac fibroblasts [RGD, Feb 2006].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte PDE2A Kategorien
PDE2A Antikörper
High quality antibodies with extensive validation data.
PDE2A Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene PDE2A Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, ELISA, IHC, IF
Validierungen
- (4)
Kat. Nr.
ABIN7147508
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, ELISA
Validierungen
- (3)
Kat. Nr.
ABIN562143
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, ELISA
Validierungen
- (1)
- (1)
Kat. Nr.
ABIN562142
Menge
50 μL
Datenblatt
Datenblatt
Empfohlene PDE2A Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1314456
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Rat
Source
Escherichia coli (E. coli)
Validierungen
Kat. Nr.
ABIN2750853
Menge
5 applications
Datenblatt
Datenblatt
Neueste Publikationen zu unseren PDE2A Produkten
: "Sustained exposure to catecholamines affects cAMP/PKA compartmentalised signalling in adult rat ventricular myocytes." in: Cellular signalling, Vol. 28, Issue 7, pp. 725-32, (2017) (PubMed).: "PDE11A negatively regulates lithium responsivity." in: Molecular psychiatry, Vol. 22, Issue 12, pp. 1714-1724, (2017) (PubMed).
: "Phosphodiesterase 2 Protects Against Catecholamine-Induced Arrhythmia and Preserves Contractile Function After Myocardial Infarction." in: Circulation research, Vol. 120, Issue 1, pp. 120-132, (2017) (PubMed).
: "In vivo model with targeted cAMP biosensor reveals changes in receptor-microdomain communication in cardiac disease." in: Nature communications, Vol. 6, pp. 6965, (2016) (PubMed).
: "Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells." in: Cellular signalling, Vol. 26, Issue 9, pp. 1807-17, (2015) (PubMed).
: "Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages." in: Journal of leukocyte biology, Vol. 96, Issue 5, pp. 907-15, (2015) (PubMed).
: "Cytokine-induced S-nitrosylation of soluble guanylyl cyclase and expression of phosphodiesterase 1A contribute to dysfunction of longitudinal smooth muscle relaxation." in: The Journal of pharmacology and experimental therapeutics, Vol. 352, Issue 3, pp. 509-18, (2015) (PubMed).
: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." in: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).
: "Expression and distribution of phosphodiesterase isoenzymes in the human male urethra." in: Urology, Vol. 85, Issue 4, pp. 964.e1-6, (2015) (PubMed).
: "Phosphodiesterase types 3 and 4 regulate the phasic contraction of neonatal rat bladder smooth myocytes via distinct mechanisms." in: Cellular signalling, Vol. 26, Issue 5, pp. 1001-10, (2014) (PubMed).
Synonyme und alternative Namen zu PDE2A
phosphodiesterase 2A (PDE2A), phosphodiesterase 2A (pde2a), phosphodiesterase 2A, cGMP-stimulated (Pde2a), phosphodiesterase 2A (Pde2a), CGS-PDE, cGSPDE, Pde2, PDE2A, PDE2A1, Pde2a2, PED2A4Bezeichner auf Proteinebene für PDE2A
- phosphodiesterase 2A, cGMP-stimulated
- cGMP-dependent 3',5'-cyclic phosphodiesterase
- phosphodiesterase 2A
- cGMP-dependent 3',5'-cyclic phosphodiesterase-like
- cGMP-stimulated phosphodiesterase 1
- cGMP-stimulated phosphodiesterase 4
- cyclic GMP-stimulated phosphodiesterase
- CGS-PDE
- cGSPDE
- cyclic GMP stimulated phosphodiesterase
- c-GMP stimulated phosphodiesterase
Sie sind hier:
